Many professionals assume their steady income means they're on track for retirement, but financial advisors see two critical mistakes that could cost hundreds of thousands: saving without a clear ...

Stock futures are pointing to a slightly lower open for major indexes on Wednesday as investors respond to a slew of earnings ...

GLP-1 weight-loss drugs are creating “mortality slippage” in life insurance which is a costly problem that's forcing insurers to rethink how they underwrite.

Treasury Secretary Scott Bessent said the U.S. is "very happy" with the current tariff situation with China, indicating there likely won't be any immediate changes to the trade truce between the two ...

The “Costanza Strategy” shows why even the worst market timing can still work out for long-term investors. Data since 1958 ...

JPMorgan's fraud expert warns that AI-powered scams are fooling even savvy consumers with perfect grammar and bank ...

Stocks fell Tuesday, led by a decline in shares of major technology companies, ahead of a flurry of retail sector earnings reports in the coming days and a key speech from Federal Reserve Chair Jerome ...

Intel shares jumped on Tuesday as investors responded to signals the Trump administration may throw the company’s troubled ...

Major U.S. equities indexes were mixed Tuesday as tech sector losses weighed on their performance. The S&P 500 ended the ...

Housing starts were higher than economists expected in July. However, builders still aren't on pace to make up for a housing ...

Seven months into President Donald Trump's campaign to rebalance global trade in America's favor, the White House can point ...

Viking Therapeutics reported a large number of patients dropped out of a study of its experimental weight-loss pill.